| answer text |
<p>In August, the Department asked suppliers to ensure they have plans in place to
air freight short shelf-life medicines, including medical radioisotopes, to avoid
any border delays that may arise at the end of March in the event of a ‘no deal’ exit
from the European Union. We continue to work closely with industry in considering
how the Department may support suppliers in making arrangements to meet this expectation,
and with NHS England to monitor medicines costs to the National Health Service. Any
increase to the list price of a branded medicine may only be made with the agreement
of the Department.</p>
|
 |
